Psilocybin-assisted treatment for alcohol dependence links mystical-type experiences and reduced craving to improved drinking outcomes in a pilot study

Psilocybin-assisted treatment for alcohol dependence centers on whether acute subjective effects help drive therapeutic change. A pilot study found that participants who had stronger mystical-type experiences and greater reductions in craving showed better drinking outcomes after treatment. The treatment combined psilocybin sessions with psychosocial support for people with alcohol dependence. Measures of drinking behavior, craving, and acute session experiences were examined to identify predictors of response. Greater intensity of certain psilocybin-related experiences was associated with improved abstinence or reduced heavy drinking, suggesting that the quality of the experience may matter alongside preparation and integration. These findings support a model in which psilocybin may aid addiction treatment through both psychological insight and lasting motivational change. The results are preliminary because of the small, open-label design, but they point toward mechanisms that can be tested in larger controlled trials.